Navin Fluorine International’s shares surged up to 13% in Mumbai amid robust first-quarter revenue growth, driven by increased demand across high-performance products, specialty chemicals, and a rapidly expanding contract development and manufacturing segment.
Navin Fluorine International rose sharply in Mumbai trade after reporting a strong first quarter, with investors responding to broad-based growth across its business lines and a marked improvement in profitability. Trade Brains reported that the stock climbed as much as 13% after the results, while ICICI Direct’s coverage of the quarter also pointed to stronger margins and healthy operating performance.
The company’s revenue increased sharply year on year, with Trade Brains citing a rise of 44.1% to ₹1,045 crore in the quarter, while ICICI Direct’s earlier note on the same results showed revenue at ₹892 crore and said growth was 47% year on year. Both reports pointed to an expansion in earnings, with net profit more than doubling in the Trade Brains article and ICICI Direct saying profit after tax rose 122% to ₹185.4 crore. The gap in reported revenue figures appears to reflect different presentation points in the market coverage, but both accounts show a strong quarter for the specialty fluorochemicals maker.
Among the three operating divisions, high-performance products remained the biggest revenue contributor. Trade Brains said the segment generated ₹540 crore, up 33% from a year earlier, helped by higher volumes and realisations, while ICICI Direct put the segment at 46% of revenue. Specialty Chemicals also delivered solid growth, with Trade Brains reporting a 48% increase to ₹325 crore and ICICI Direct describing the segment as 40% of revenue, up 60% year on year. The company said demand, order visibility and the ramp-up of existing molecules all supported the performance.
The fastest-growing business, however, was contract development and manufacturing, or CDMO, which serves pharmaceutical and other customers under long-term development and production arrangements. Trade Brains said CDMO revenue rose 82% to ₹180 crore, while ICICI Direct reported growth of 61% and a 14% share of group revenue. Trade Brains said the segment benefited from stronger order momentum and deeper ties with international partners, particularly a leading European client, while the company also outlined further capital spending at its Surat plant and other expansion projects. For investors, the key takeaway is that high-performance products still anchor the business, but CDMO is increasingly the main growth engine.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
